Literature DB >> 12941796

BP75, bromodomain-containing M(r) 75,000 protein, binds dishevelled-1 and enhances Wnt signaling by inactivating glycogen synthase kinase-3 beta.

Sunhong Kim1, Jiwoon Lee, Jeehye Park, Jongkyeong Chung.   

Abstract

To identify novel regulators of Wnt signaling, we performed yeast two-hybrid analyses with Dvl-1 and identified BP75 as a candidate. Here, we demonstrated that BP75 directly interacts with Dvl-1 in mammalian cells and enhances TCF-dependent gene expression induced by Dvl-1. In support of these results, BP75 in cooperation with Dvl-1 was found to facilitate dephosphorylation at Tyr216 of glycogen synthase kinase-3beta and consequently inhibit its kinase activity. Furthermore, the nuclear translocation and formation of vesicular structures of beta-catenin were induced by BP75 and Dvl-1 in a synergistic manner. Collectively, these results provided us a novel mechanism in Wnt signaling where BP75 plays important regulatory roles between glycogen synthase kinase-3beta and Dvl.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12941796

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  12 in total

Review 1.  PTPN13/PTPL1: an important regulator of tumor aggressiveness.

Authors:  Gilles Freiss; Dany Chalbos
Journal:  Anticancer Agents Med Chem       Date:  2011-01       Impact factor: 2.505

2.  Inhibition of ERK-MAP kinase signaling by RSK during Drosophila development.

Authors:  Myungjin Kim; Jun Hee Lee; Hyongjong Koh; Soo Young Lee; Cholsoon Jang; Cecilia J Chung; Jung Hwan Sung; John Blenis; Jongkyeong Chung
Journal:  EMBO J       Date:  2006-06-08       Impact factor: 11.598

3.  PAF-AH Catalytic Subunits Modulate the Wnt Pathway in Developing GABAergic Neurons.

Authors:  Idit Livnat; Danit Finkelshtein; Indraneel Ghosh; Hiroyuki Arai; Orly Reiner
Journal:  Front Cell Neurosci       Date:  2010-05-28       Impact factor: 5.505

4.  Pteisolic acid G, a novel ent-kaurane diterpenoid, inhibits viability and induces apoptosis in human colorectal carcinoma cells.

Authors:  Shuangli Qiu; Xin Wu; Hongbo Liao; Xiaobin Zeng; Senwang Zhang; Xiaofen Lu; Xiaohong He; Xiaoqi Zhang; Wencai Ye; Hua Wu; Xiaohui Zhu
Journal:  Oncol Lett       Date:  2017-09-06       Impact factor: 2.967

Review 5.  Manipulation of glycogen-synthase kinase-3 activity in KSHV-associated cancers.

Authors:  Masahiro Fujimuro; S Diane Hayward
Journal:  J Mol Med (Berl)       Date:  2004-01-09       Impact factor: 4.599

6.  Bromodomain protein 7 interacts with PRMT5 and PRC2, and is involved in transcriptional repression of their target genes.

Authors:  Sookil Tae; Vrajesh Karkhanis; Kevin Velasco; Mariana Yaneva; Hediye Erdjument-Bromage; Paul Tempst; Saïd Sif
Journal:  Nucleic Acids Res       Date:  2011-03-29       Impact factor: 16.971

7.  Targeting the anaphase-promoting complex/cyclosome (APC/C)- bromodomain containing 7 (BRD7) pathway for human osteosarcoma.

Authors:  Kaishun Hu; Dan Liao; Wenjing Wu; An-Jia Han; Hui-Juan Shi; Fen Wang; Xin Wang; Li Zhong; Tingmei Duan; Yuanzhong Wu; Jingying Cao; Jianjun Tang; Yi Sang; Li Wang; Xiaobin Lv; Shuangbing Xu; Ru-Hua Zhang; Wu-Guo Deng; Sheng-Ping Li; Yi-Xin Zeng; Tiebang Kang
Journal:  Oncotarget       Date:  2014-05-30

8.  Transcriptional regulation of BRD7 expression by Sp1 and c-Myc.

Authors:  Huaying Liu; Ming Zhou; Xiaomin Luo; Liming Zhang; Zhaoxia Niu; Cong Peng; Jian Ma; Shuping Peng; Houde Zhou; Bo Xiang; Xiayu Li; Shufang Li; Jiajin He; Xiaoling Li; Guiyuan Li
Journal:  BMC Mol Biol       Date:  2008-12-27       Impact factor: 2.946

9.  Signaling Transduction Network Mediated by Tumor Suppressor/Susceptibility Genes in NPC.

Authors:  Minghua Wu; Xiayu Li; Xiaoling Li; Guiyuan Li
Journal:  Curr Genomics       Date:  2009-06       Impact factor: 2.236

10.  Development of neurodevelopmental disorders: a regulatory mechanism involving bromodomain-containing proteins.

Authors:  Junlin Li; Guifang Zhao; Xiaocai Gao
Journal:  J Neurodev Disord       Date:  2013-02-20       Impact factor: 4.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.